# Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib)

> **NCT04264546** · PHASE1,PHASE2 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 60 (actual)

## Conditions studied

- Polio

## Interventions

- **BIOLOGICAL:** sIPV

## Key facts

- **NCT ID:** NCT04264546
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-24
- **Primary completion:** 2018-03-09
- **Final completion:** 2018-12-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04264546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04264546, "Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04264546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*